The abstract is read at the publisher; the summary is JClub's.
In Nepal’s pre-eclampsia prevention pathway, low-dose aspirin adoption and uptake are limited by interdependent gaps across antenatal engagement, screening, prescribing, and counselling, based on 73 qualitative interviews.
- Why it matters: Even with evidence for low-dose aspirin to prevent pre-eclampsia in at-risk women, real-world implementation is suboptimal, and the specific pathway-level barriers remain unclear.
- What they did: The study used purposive sampling from three tertiary hospitals and maternal health organizations in Nepal, conducting semi-structured interviews with 36 pregnant women, 29 providers, and 8 stakeholders, analyzed via rapid qualitative methods organized by the COM-B model.
- The result: Delayed antenatal care and inconsistent screening reduced timely risk identification, while gaps in national guidance and standardized prescribing protocols led to variable prescribing; among prescribed women, counselling on purpose and safety plus trust supported uptake.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.